Literature DB >> 3180907

Steady-state kinetics of proguanil and its active metabolite, cycloguanil, in man.

M D Edstein1, J R Veenendaal, H V Scott, K H Rieckmann.   

Abstract

The pharmacokinetics of proguanil and its active metabolite, cycloguanil, were determined at steady-state in 6 healthy male volunteers after daily administration of 2 Paludrine tablets (200 mg proguanil hydrochloride). A maximum plasma proguanil concentration of 130.3 +/- 16.0 ng/ml (mean +/- SD) was reached at 3.8 +/- 1.3 h while a maximum cycloguanil concentration of 52.0 +/- 15.2 ng/ml was obtained at 5.3 +/- 1.0 h after dosing. The elimination half-lives of proguanil and cycloguanil were 14.5 +/- 3.0 h and 11.7 +/- 3.1 h, respectively. The plasma clearance of proguanil was 1.43 +/- 0.33 l/h/kg and the apparent volume of distribution was 30.7 +/- 12.3 l/kg. Renal clearance of proguanil (0.33 +/- 0.19 l/h/kg) was about 23% of the plasma clearance and 35.6 +/- 9.6% of the oral dose was recovered as proguanil and cycloguanil.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3180907     DOI: 10.1159/000238597

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  4 in total

1.  Single dose pharmacokinetics of proguanil and its metabolites in pregnancy.

Authors:  J Wangboonskul; N J White; F Nosten; F ter Kuile; R R Moody; R B Taylor
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

2.  In vitro proguanil activation to cycloguanil by human liver microsomes is mediated by CYP3A isoforms as well as by S-mephenytoin hydroxylase.

Authors:  D J Birkett; D Rees; T Andersson; F J Gonzalez; J O Miners; M E Veronese
Journal:  Br J Clin Pharmacol       Date:  1994-05       Impact factor: 4.335

3.  Metabolic disposition of proguanil in extensive and poor metabolisers of S-mephenytoin 4'-hydroxylation recruited from an Indonesian population.

Authors:  R Setiabudy; M Kusaka; K Chiba; I Darmansjah; T Ishizaki
Journal:  Br J Clin Pharmacol       Date:  1995-03       Impact factor: 4.335

4.  In silico analysis for factors affecting anti-malarial penetration into red blood cells.

Authors:  Natapol Pornputtapong; Bovornpat Suriyapakorn; Anchisa Satayamapakorn; Kanidsorn Larpadisorn; Pariyachut Janviriyakul; Phisit Khemawoot
Journal:  Malar J       Date:  2020-06-23       Impact factor: 2.979

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.